A Randomized Trial Comparing Insulin Lispro Protamine Suspension With Insulin Glargine in Subjects With Type 2 Diabetes on Oral Antihyperglycemic Medications and Exenatide.
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2014
At a glance
- Drugs Insulin neutral protamine lispro (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 24 Sep 2010 Results presented at the 46th Annual Meeting of the European Association for the Study of Diabetes.
- 25 Jun 2010 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History